Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPRE
āļāļ·āđāļāļāļĢāļīāļĐāļąāļPrenetics Global Ltd
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 06, 2021
āļāļĩāļāļĩāđāļKwok (Samantha)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ285
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļJul 06
āļāļĩāđāļāļĒāļđāđUnit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
āđāļĄāļ·āļāļ
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻHong Kong
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ- -
āđāļāļĢāļĻāļąāļāļāđ85222109588
āđāļ§āđāļāđāļāļāđhttps://ir.prenetics.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPRE
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļJul 06, 2021
āļāļĩāļāļĩāđāļKwok (Samantha)
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
Mr. Brian J. Rosin
Chief Financial Officer-Designate
Chief Financial Officer-Designate
Mr. Hudson Leogrande
Independent Director
Dr. Darshan Shah
Independent Director
Mr. David Vanderveen
Independent Director
Ms. Caroline S. Levy
Independent Director
Mr. Alan Thomas
Vice President, Supply Chain & Operations
Vice President, Supply Chain & Operations
Ms. Jordan Lemerande
Vice President - Product Development
Vice President - Product Development
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Hoi Chun (Stephen) Lo
Mr. Hoi Chun (Stephen) Lo
Chief Financial Officer
Mr. Sheng Wu (Danny) Yeung
Mr. Sheng Wu (Danny) Yeung
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
Mr. Brian J. Rosin
Chief Financial Officer-Designate
Chief Financial Officer-Designate
Mr. Hudson Leogrande
Independent Director
Dr. Darshan Shah
Independent Director
Mr. David Vanderveen
Independent Director